The company's ROE is acceptable but not exceptional. The combination of low ROE and high debt increases risk and limits future options. High ROE without much debt usually indicates a good quality business.
Despite the strong earnings outlook and growth expected to outpace the market, Shanghai Runda Medical Technology’s P/E is below most other companies, suggesting shareholders may be doubtful of the forecasts or anticipating earnings instability.
Shanghai Runda Medical Technology Stock Forum
No comment yet